(Total Views: 100)
Posted On: 02/01/2025 9:46:45 AM
Post# of 586
Encouraging most importantly because clearly the previous administration sat on their hands awaiting the new administration. JMO the FDA would appear to
have been receptive in the 1/28 meeting to have encouraged the company to submit their follow up answers. "With these matters resolved, the company expects to submit to the FDA its additional responses addressing all preclinical and clinical comments, in early February." PROGRESS!
$5-$10+
have been receptive in the 1/28 meeting to have encouraged the company to submit their follow up answers. "With these matters resolved, the company expects to submit to the FDA its additional responses addressing all preclinical and clinical comments, in early February." PROGRESS!
$5-$10+
(0)
(0)
